Literature DB >> 11602124

[EuroQol-5D: a simple alternative for measuring health-related quality of life in primary care].

M Herdman1, X Badia, S Berra.   

Abstract

Mesh：

Year:  2001        PMID： 11602124     DOI： 10.1016/s0212-6567(01)70406-4

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  78 in total

1.  Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMART.

Authors:  Sarah A Kelleher; Caroline S Dorfman; Jen C Plumb Vilardaga; Catherine Majestic; Joseph Winger; Vicky Gandhi; Christine Nunez; Alyssa Van Denburg; Rebecca A Shelby; Shelby D Reed; Susan Murphy; Marie Davidian; Eric B Laber; Gretchen G Kimmick; Kelly W Westbrook; Amy P Abernethy; Tamara J Somers
Journal:  Contemp Clin Trials       Date:  2017-04-11       Impact factor: 2.226

2.  Pre Frail 80: Multifactorial Intervention to Prevent Progression of Pre-Frailty to Frailty in the Elderly.

Authors:  L Gené Huguet; M Navarro González; B Kostov; M Ortega Carmona; C Colungo Francia; M Carpallo Nieto; A Hervás Docón; R Vilarrasa Sauquet; R García Prado; A Sisó-Almirall
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

3.  Feasibility and Preliminary Outcomes of a Web and Smartphone-Based Medication Self-Management Platform for Chronically Ill Patients.

Authors:  Helena Anglada-Martínez; Maite Martin-Conde; Marina Rovira-Illamola; Jose Miguel Sotoca-Momblona; Ethel Sequeira; Valentin Aragunde; M Angels Moreno; Marta Catalan; Carles Codina-Jané
Journal:  J Med Syst       Date:  2016-02-12       Impact factor: 4.460

4.  Influence of nutritional status on health-related quality of life of non-institutionalized older people.

Authors:  S Jiménez-Redondo; B Beltrán de Miguel; J Gavidia Banegas; L Guzmán Mercedes; J Gómez-Pavón; C Cuadrado Vives
Journal:  J Nutr Health Aging       Date:  2014-04       Impact factor: 4.075

5.  [Gender differences in health status in a population of over 85 year-olds: the Octabaix study].

Authors:  Assumpta Ferrer; Teresa Badía; Francesc Formiga; Jesús Almeda; Coral Fernández; Ramón Pujol
Journal:  Aten Primaria       Date:  2011-03-05       Impact factor: 1.137

6.  A comparison of telephone and paper self-completed questionnaires of main patient-related outcome measures in patients with ankylosing spondylitis and psoriatic arthritis.

Authors:  Rafael Ariza-Ariza; Blanca Hernández-Cruz; Victoria Navarro-Compán; Christian Leyva Pardo; Xavier Juanola; Federico Navarro-Sarabia
Journal:  Rheumatol Int       Date:  2013-06-21       Impact factor: 2.631

7.  Improvement in OMERACT domains and renal function with regular treatment for gout: a 12-month follow-up cohort study.

Authors:  Janitzia Vazquez-Mellado; Ingris Peláez-Ballestas; Rubén Burgos-Vargas; Everardo Alvarez-Hernández; Sergio García-Méndez; Virginia Pascual-Ramos; Marina Rull-Gabayet
Journal:  Clin Rheumatol       Date:  2018-03-15       Impact factor: 2.980

8.  Health-related quality of life in unselected outpatients with heart failure across Spain in two different health care levels. Magnitude and determinants of impairment: the INCA study.

Authors:  Beatriz de Rivas; Gaietà Permanyer-Miralda; Carlos Brotons; Joaquín Aznar; Eduardo Sobreviela
Journal:  Qual Life Res       Date:  2008-10-15       Impact factor: 4.147

9.  Pain, disability and health-related quality of life in osteoarthritis-joint matters: an observational, multi-specialty trans-national follow-up study.

Authors:  Antonio Montero; Juan-Francisco Mulero; Carlos Tornero; Jordi Guitart; Mar Serrano
Journal:  Clin Rheumatol       Date:  2016-04-11       Impact factor: 2.980

10.  Management of sleep apnea without high pretest probability or with comorbidities by three nights of portable sleep monitoring.

Authors:  Arnoldo Guerrero; Cristina Embid; Valentina Isetta; Ramón Farre; Joaquin Duran-Cantolla; Olga Parra; Ferran Barbé; Josep M Montserrat; Juan F Masa
Journal:  Sleep       Date:  2014-08-01       Impact factor: 5.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.